SymBio Pharmaceuticals

SymBio Pharmaceuticals is a pharmaceutical company known for its focus on developing treatments for rare diseases and cancers. The company was founded in 2005 and has a strong emphasis on research and development in oncology and hematology. SymBio Pharmaceuticals has developed drugs for various indications, including therapies for malignant lymphoma, leukemia, and solid tumors. They are committed to creating innovative and effective treatments for patients with unmet medical needs.